Arcus Biosciences (RCUS) Income towards Parent Company (2017 - 2026)
Arcus Biosciences' Income towards Parent Company was -$91 million in Q2 2026.
Powered by 
Analysis
Arcus Biosciences (RCUS) Income towards Parent Company (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Arcus Biosciences' Income towards Parent Company was -$460 million through Jun 30, 2026; for FY2025, it came in at -$353 million.
- In earlier years, Income towards Parent Company was -$283 million in FY2024, -$307 million in FY2023, -$267 million in FY2022 and $53 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Income towards Parent Company since Q1 2024.
- Per Business Quant data, RCUS's Income towards Parent Company in the three quarters before Q2 2026 was -$128 million (Q1 2026), -$106 million (Q4 2025) and -$135 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Arcus Biosciences | 3.11 Bn | -229.58 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -91.00 Mn |
| Mar 31, 2026 | -128.00 Mn |
| Dec 31, 2025 | -106.00 Mn |
| Sep 30, 2025 | -135.00 Mn |
| Mar 31, 2025 | -112.00 Mn |
| Dec 31, 2024 | -94.00 Mn |
| Sep 30, 2024 | -92.00 Mn |
| Jun 30, 2024 | -93.00 Mn |
| Mar 31, 2024 | -4.00 Mn |
| Dec 31, 2023 | -81.00 Mn |
| Sep 30, 2023 | -71.00 Mn |
| Jun 30, 2023 | -75.00 Mn |
| Mar 31, 2023 | -80.00 Mn |
| Dec 31, 2022 | -67.00 Mn |
| Sep 30, 2022 | -65.00 Mn |
| Jun 30, 2022 | -67.00 Mn |
| Mar 31, 2022 | -68.00 Mn |
| Dec 31, 2021 | 279.54 Mn |
| Sep 30, 2021 | -77.98 Mn |
| Jun 30, 2021 | -75.97 Mn |
API Access
Arcus Biosciences Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=RCUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "RCUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=RCUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();